| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/10/1998 | US5716980 Alcohol or aldehyde derivatives and their use |
| 02/10/1998 | US5716959 Administering substituted piperazines having hydroxy- or amino-alkyl groups on one nitrogen and carboxylic, phosphoric or sulfonic alkyl groups on the other nitrogen, for treatment of cancer and autoimmune diseases |
| 02/10/1998 | US5716957 Administering a hypoglycemic agent or dopaminergic agent once a day and within two hours after waking in morning |
| 02/10/1998 | US5716955 Cytokine inhibitor |
| 02/10/1998 | US5716949 Heterocyclic compounds |
| 02/10/1998 | US5716945 Antiinflammatory agents; immunostimulation; cell differentiation; antigrowth agents |
| 02/10/1998 | US5716942 Treatment of migraine with morpholine tachykinin receptor antagonists |
| 02/10/1998 | US5716619 Treatment of type 2 diabetes mellitus |
| 02/10/1998 | CA2053258C Use of non-absorbable synthetic sulfated polysaccharides to decrease cholesterol absorption |
| 02/10/1998 | CA1339663C 1-acyl-2,3-dihydro-4(1h)-quinolinone-4-oxime derivate, processfor producingthem and use thereof |
| 02/10/1998 | CA1339661C Cycloalkylamides of (8b)-1alkyl-6 (substituted)ergolines |
| 02/06/1998 | CA2212204A1 8-substituted b-nor-6-thiaequilenin compounds having activity as selective estrogen receptor modulators |
| 02/05/1998 | WO1998004913A1 Molecular model for vla-4 inhibitors |
| 02/05/1998 | WO1998004734A1 Synthetic protein folding catalysis |
| 02/05/1998 | WO1998004693A2 Secreted proteins and polynucleotides encoding them |
| 02/05/1998 | WO1998004688A1 Egf-like factor from chromaffin granules and glia cell-derived neurotrophic factor with survival-promoting activity on daergic neurons |
| 02/05/1998 | WO1998004682A1 Adipogenic differentiation of human mesenchymal stem cells |
| 02/05/1998 | WO1998004591A1 Novel parathyroid hormone-related peptide analogs |
| 02/05/1998 | WO1998004583A1 Conformationally constrained backbone cyclized somatostatin analogs |
| 02/05/1998 | WO1998004528A2 Substituted pyridines and biphenyls as anti-hypercholesterinemic, anti-hyperlipoproteinemic and anti-hyperglycemic agents |
| 02/05/1998 | WO1998004526A1 SUBSTITUTED SULFONAMIDES AS SELECTIVE β3 AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY |
| 02/05/1998 | WO1998004248A1 Dietary supplements |
| 02/05/1998 | WO1998004247A1 Cell adhesion inhibitors |
| 02/05/1998 | WO1997049736A3 Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications |
| 02/05/1998 | WO1997047744A3 T-cell selective interleukin-4 agonists |
| 02/05/1998 | WO1997038084A3 Polynucleotides derived from a pbmc cdna library encoding secreted proteins |
| 02/05/1998 | CA2289699A1 Secreted proteins and polynucleotides encoding them |
| 02/05/1998 | CA2262434A1 Substituted pyridines and biphenyls as anti-hypercholesterinemic, anti-hyperlipoproteinemic and anti-hyperglycemic agents |
| 02/05/1998 | CA2261974A1 Molecular model for vla-4 inhibitors |
| 02/05/1998 | CA2261764A1 Dietary supplements |
| 02/05/1998 | CA2261167A1 Substituted sulfonamides as selective .beta.3 agonists for the treatment of diabetes and obesity |
| 02/04/1998 | EP0822255A2 CHO (Chinese Hamster Ovary) glycosylated antibodies and their use in therapy |
| 02/04/1998 | EP0822199A2 N-terminally monopegylated polypeptides and process for their preparation. |
| 02/04/1998 | EP0822185A1 B-3-adrenergic agonists as antidiabetic and antiobesity agents |
| 02/04/1998 | EP0822182A1 Substituted indanylidineacetylguanidines as Na+/H+ exchange inhibitors, process for their preparation, their use as medicaments or diagnostic agents and medicaments containing them |
| 02/04/1998 | EP0821951A1 Process for preparing a bicarbonate-containing infusion- or dialysis solution |
| 02/04/1998 | EP0821950A2 Clear hydroalcoholic solution of multivitamins containing physiologically active quantity of beta-carotene |
| 02/04/1998 | EP0821741A1 Glucose-inducible recombinant viral vector |
| 02/04/1998 | EP0821728A1 Tie-2 ligands, methods of making and uses thereof |
| 02/04/1998 | EP0821665A1 Cyclobutane derivatives as inhibitors of squalene synthase and protein farnesyltransferase |
| 02/04/1998 | CN1172435A Use of non-mammalian DNA virus to express exogenous gene in mammalian cell |
| 02/04/1998 | CN1172432A Method of decreasing serum calcium levels |
| 02/04/1998 | CN1172104A Substituted lndanylidineacetylguanidines, process for their preparation, their use as medicaments of diagnostic and medicaments containing them |
| 02/04/1998 | CN1171966A Health-care tea for preventing angiocardiopathy or cerebrovascular diseases and its preparing method |
| 02/03/1998 | US5714519 Administering pantethine at predetermined time of day |
| 02/03/1998 | US5714514 2-Cyano-3-mercaptocrotonamides |
| 02/03/1998 | US5714381 DNA encoding human alpha 1 adrenergic receptors and uses thereof |
| 02/03/1998 | US5714138 Polyaspartamide derivatives as adsorbents for bile acids, polyaspartamide derivatives loaded with bile acids and process for their preparation and their use as pharmaceuticals |
| 02/03/1998 | CA2128093C 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxoquinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents |
| 02/03/1998 | CA1339660C Derivatives of cyclohexane |
| 01/31/1998 | CA2211866A1 .beta.-adrenergic agonists |
| 01/29/1998 | WO1998003671A1 Process for preparing docosahexaenoic acid and docosapentaenoic acid |
| 01/29/1998 | WO1998003547A1 Antagonists of intestinotrophic glp-2 peptides |
| 01/29/1998 | WO1998003507A1 Pyrazolopyridine compound and pharmaceutical use thereof |
| 01/29/1998 | WO1998003494A1 Certain amido- and amino-substituted benzylamine derivatives; a new class of neuropeptite y1 specific ligands |
| 01/29/1998 | WO1998003493A1 Certain substituted benzylamine derivatives; a new class of neuropeptide-y1 specific ligands |
| 01/29/1998 | WO1998003492A1 Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands |
| 01/29/1998 | WO1998003484A1 Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 01/29/1998 | WO1998003081A1 Method of improving the growth or the efficiency of feed conversion of an animal and compositions for use therein |
| 01/29/1998 | WO1998003069A1 Method for lowering serum lipid levels employing an mtp inhibitor in combination with another cholesterol lowering drug |
| 01/29/1998 | WO1998003059A1 Galanin |
| 01/29/1998 | CA2261031A1 Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands |
| 01/29/1998 | CA2260995A1 Method for lowering serum lipid levels employing an mtp inhibitor in combination with another cholesterol lowering drug |
| 01/29/1998 | CA2260990A1 Pyrazolopyridine compound and pharmaceutical use thereof |
| 01/29/1998 | CA2260983A1 Certain amido- and amino-substituted benzylamine derivatives; a new class of neuropeptite y1 specific ligands |
| 01/29/1998 | CA2260982A1 Certain substituted benzylamine derivatives; a new class of neuropeptide-y1 specific ligands |
| 01/28/1998 | EP0821068A2 Novel sphingolipids and a process thereto |
| 01/28/1998 | EP0821061A2 Calcitonin gene-related peptide receptor component factor (houdc44) |
| 01/28/1998 | EP0821006A2 Derivatives of insulin having enhanced zinc binding activity |
| 01/28/1998 | EP0821004A1 Novel peptides and remedy for bone diseases containing the same as active ingredient |
| 01/28/1998 | EP0820988A2 Imino derivatives as bone resorption inhibitors and vitronectin receptor antagonists |
| 01/28/1998 | EP0820773A1 Treatment of diabetes with a glucokinase gene |
| 01/28/1998 | EP0820469A1 Identification, purification and uses of leczymes and carbohydrate ligands |
| 01/28/1998 | EP0820455A1 5H, 10H-IMIDAZO [1,2-a]INDENO [1,2-e]PYRAZIN-4-ONE DERIVATIVES, PREPARATION THEREOF, AND DRUGS CONTAINING SAID DERIVATIVES |
| 01/28/1998 | EP0820451A1 Novel heterocyclic compounds |
| 01/28/1998 | EP0820450A1 Novel heterocyclic compounds |
| 01/28/1998 | EP0820445A1 Inhibitors of farnesyl-protein transferase |
| 01/28/1998 | EP0820442A1 Novel heterocyclic compounds |
| 01/28/1998 | EP0820441A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS |
| 01/28/1998 | EP0820433A1 O-malonyltyrosyl compounds, o-malonyltyrosyl compound-containing peptides, and uses thereof |
| 01/28/1998 | EP0820428A1 Terminal carboxy or tetrazole groups containing dialkyl ethers |
| 01/28/1998 | EP0820303A1 PEPTIDE p277 ANALOGS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM FOR TREATMENT OR DIAGNOSIS OF DIABETES |
| 01/28/1998 | EP0752886B1 Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes |
| 01/28/1998 | EP0606318B1 Vanadium compositions |
| 01/28/1998 | CN1171816A CDNA encoding BMP type II receptor |
| 01/28/1998 | CN1171787A Pyridazinoquinoline compounds |
| 01/27/1998 | US5712312 Melatoninergic receptor ligands, treatment of sleep disorders |
| 01/27/1998 | US5712291 Methods and compositions for inhibition of angiogenesis |
| 01/27/1998 | US5712283 Method of inhibiting hyperglycemia and pharmaceutical composition for use therein |
| 01/27/1998 | US5712279 Inhibitors of microsomal triglyceride transfer protein and method |
| 01/27/1998 | US5712277 Use of 3,5-diamino-6-(2,3-dichlororophenyl) -1,2,4-triazine for the treatment of pain and oedema |
| 01/27/1998 | US5712265 Administration of pirenzepine, methyl scopolamine and other muscarinin receptor antagonists for treatment of glucose metabolism disorders |
| 01/27/1998 | US5712253 Macrocyclic 13-membered ring derivatives of erythromycins A and B |
| 01/27/1998 | US5711983 Dinoflagellate biomass, methods for its production, and compositions containing the same |
| 01/27/1998 | CA2092401C Quaternary ammonium salts derived from chitosan |
| 01/24/1998 | CA2211148A1 Novel imino derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 01/22/1998 | WO1998002172A1 Methods of enhancing lean tissue mass and bone mineral content and compositions therefor |
| 01/22/1998 | WO1998002165A1 Appetite suppression |
| 01/22/1998 | WO1998002159A1 Novel treatment of leptine resistance |
| 01/22/1998 | CA2260892A1 Appetite suppression |